课题基金 / 基金详情

Study on the Molecule That Plays Critical Role in Allergic Response.

Study on the Molecule That Plays Critical Role in Allergic Response.
在过敏反应中起关键作用的分子的研究。
批准号:
12670732
负责人:
MORIO Tomohiro
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

MORIO Tomohiro的其他基金

相似基金

相关文献

中文摘要
翻译
当B细胞受到IL-4R/CD40刺激时,与CD40相关的Ku70/80易位进入细胞核。同样的刺激也会导致IgE低亲和力受体(CD23)的最大表达。这些数据提示Ku70/80在CD23表达调控中发挥作用。我们制备了两种不同的显性阴性(DN) Ku80作为egfp融合蛋白,将它们转染到ddn - 39b细胞系中,并检测了对IL-4R/ cd40驱动的CD23表达的影响。缺乏C端Ku80的DN构建体之一抑制IL-4R/ cd40驱动的CD23表达。我们采用报告基因试验来了解EBVRE是否具有CD23表达增强剂的功能。我们的研究表明,当B细胞受到IL-4和抗cd40刺激时,Ku结合位点周围的区域(EBVRE)表现出增强作用。然而,我们无法在EMSA实验中证明Ku70/80实际上占据了该区域。这些结果表明Ku70/80调控CD23的表达。我们已经开始观察Ku70/80对cd40驱动的CD95 (Fas)表达的影响,并确定了CD95启动子区域的ku结合位点。另一个兴趣是Ku70/80的修改及其对Ku70/80函数的影响。我们的研究表明,应激反应导致Ku70/80的降解,这种降解是由丝氨酸蛋白酶或Ku70/80的泛素化介导的。我们现在正在研究降解是否导致细胞凋亡或停止过敏反应。据报道,AID对免疫球蛋白类转换很重要。我们对16例非x连锁超igm综合征的AID进行了测序,发现9例发生突变。我们现在正在研究Ku70/80和AID之间是否存在任何生理或功能上的相互作用。
英文摘要
Ku70/80 that associates with CD40 translocates into the nucleus when B cells are stimulated through IL-4R/CD40. The same stimulation also leads to maximal expression of low affinity receptor for IgE (CD23). These data suggest that Ku70/80 plays a role in the regulation of CD23 expression. We have generated two different dominant negative (DN) constructs for Ku80 as EGFP-fusion proteins, transfected them into DND-39 B cell line, and examined the effect on IL-4R/CD40-driven CD23 expression. One of the DN constructs that lacks C terminal Ku80 inhibited IL-4R/CD40-driven CD23 expression.We have employed reporter gene assay to know whether EBVRE functions as enhancer of CD23 expression. Our study has shown that the region encompassing the Ku binding site (EBVRE) shows enhancing effect when B cells were stimulated with IL-4 and anti-CD40. We could not, however, show that Ku70/80 actually occupies the region in EMSA assay. These results suggest that Ku70/80 regulates expression of CD23.We have started looking at the effect of Ku70/80 on CD40-driven CD95 (Fas) expression and has determined Ku-binding site in the promoter region of CD95.Another interest is the modification of Ku70/80 and its effect on the Ku70/80function. Our study indicated that stress response leads to degradation of Ku70/80 that is mediated by serine protease or ubiquitination of Ku70/80. We are now examining whether the degradation results in apoptosis of the cells or in cessation of allergic response.AID is reported to be important for Immunoglobulin class switch. We have sequenced AID from 16 cases of non-X-linked hyper-IgM syndrome and found mutation in 9 cases. We are now examining whether there is any physiological or functional interaction between Ku70/80 and AID.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
Ito S, et al.: "Mutations of the WASP gene in ten Japanese patients with WIskott-Aldrich syndrome and X-linked thrombocytopenia"International Hematology. 71. 79-83 (2000)
Ito S 等人:“10 名患有 WIskott-Aldrich 综合征和 X 连锁血小板减少症的日本患者中 WASP 基因的突变”国际血液学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kawai S, et al.: "Flow cytometric determination of intracytoplasmic Wiskott-Aldrich syndrome protein in peripheral blood lymphocyte subpopulations"Journal of Immunological Method. 260. 195-205 (2002)
Kawai S 等人:“外周血淋巴细胞亚群中胞浆内 Wiskott-Aldrich 综合征蛋白的流式细胞术测定”免疫学方法杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kumaki S,Ishii N,Ohashi Y, et al. (28名、8番目): "Characterization of the γc chain among 27 unrelated Japanese patients with X-linked severe combined immunodeficiency (X-SCID)"Human Genetics. 107. 406-408 (2000)
Kumaki S、Ishii N、Ohashi Y 等人(28 人,第 8 名):“27 名不相关的日本 X 连锁严重联合免疫缺陷 (X-SCID) 患者的 γc 链特征”人类遗传学 107。 408(2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nagasawa M, et al.: "ln vitro class switch of B cells after cord blood stem cell transplantation in severe combined immune deficient (SCID) patient"American Journal of Hematology. 65. 176-179 (2000)
Nagasawa M 等人:“严重联合免疫缺陷 (SCID) 患者脐带血干细胞移植后 B 细胞的体外类别转换”美国血液学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 15 条
    Study on pathogenesis of disorders caused by neutrophil dysfunction using novel analytical techniques and development of an innovative strategy to control neutrophils
    • 批准号:
      25670472
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      MORIO Tomohiro
    • 依托单位:
    Research on molecular mechanisms of break in immunological tolerance in disorders caused by single-gene defect
    • 批准号:
      23390270
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2011
    • 负责人:
      MORIO Tomohiro
    • 依托单位:
    Study on molecules that negatively regulate ROS production in human granulocyes
    • 批准号:
      23659518
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      MORIO Tomohiro
    • 依托单位:
    Study on the mechanism of autoimmunity and malignancy developed in primary immunodeficiency
    • 批准号:
      20591245
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      MORIO Tomohiro
    • 依托单位:
    国内基金
    海外基金
    吐温80-DNAPL协同作用下粘土层优势渗流通道形成机制
    基于 INO80B-SLC31A2 轴的染色质重塑与铜死亡调控机制在激素性股骨头坏死中的关键作用与干预研究
    • 批准号:
      ZCLMS26H0602
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      陈春
    • 依托单位:
    EB病毒蛋白BZLF1上调CD40/CD40L- KU80/RAG信号通路促进BCR二次重排在机 体丧失自身免疫耐受的机制
    尿毒症毒素上调YY1表达进而招募INO80复合物在肾纤维化中的机制研究